Scholars Central

Conference abstract

Design and manufacture of applicable delivery system for toxic drugs

Authors: Zhijun Yang

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The most recent report by the Tufts Center for the average cost to develop and gain marketing approval for a new drug pegged at $2.558 billion. However, to develop a proper delivery system for the marketed biologic entities must cost very little for improving their therapeutic effect and decrease the side. We have successfully achieved the preparation of intact solid lipid nanovesicles that carry active pharmaceutical ingredients (API) and upon rehydration form liposomes with controlled drug release capability. To demonstrate these solid lipid nanovesicles, which were prepared by lyophilizing the mixture of liposomes combined without or with ligands such as DSS or CA9, entrapped water-soluble API such as albuterol, siRNA or insulin, mixed with cryoprotectant lactose and a plasticizer glycerol and water. Our data shows the release of encapsulated albuterol with linear types from rehydrated liposomes in Tris-buffered saline and the TEM micrographs were token of solid lipid nanovesicles. Liposome structure, entrapped API and controlled release capability were retained after lyophilization and rehydration, and the in vivo delivery effectives were confirmed. Since solid lipid nanovesicles are more adaptable than liposomes or other nanoparticles to a wide variety of APIs and dosage forms, our novel invention allows a much wider usage of liposome technology in numerous pharmaceutical, chemical and biological situations. We are authorized the patent from China for the application of the solid lipid nanovesicles, it can be used to develop many well-known biologic entities with strongest toxicity, e.g. triptolide, podophyllotoxin, etc., to some new cancer therapeutic entities.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmacovigilance.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmacovigilance
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Zhijun Yang”